Zhengye Biotechnology Holding Limited ZYBT
1.31 USD -0.03 (-2.16%)
Nov 4, 2026, 10:11 AM EST
1.29 Day range 1.37
0.616 52-week range 8.01
- YTD
- +14.00%
- 1 year
- -40.95%
Financial health
Altman Z-Score
1.51 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -5.7×
FY 2021 5y median 36.3× FY 2025
P/S 3.3×
FY 2021 5y median 6.6× FY 2025
P/B 1.5×
FY 2021 5y median 5.3× FY 2025
P/FCF 542×
FY 2021 5y median 126× FY 2025
EV/EBITDA -9.5×
FY 2021 5y median 20.4× FY 2025
EV/Sales 3.5×
FY 2021 5y median 6.7× FY 2025
FCF Yield 0.2%
FY 2021 5y median 0.4% FY 2025
Profitability
Gross Margin 20.5%
FY 2021 5y median 58.6% FY 2025
Operating Margin -58.7%
FY 2021 5y median 21.3% FY 2025
Net Margin -60.0%
FY 2021 5y median 14.9% FY 2025
ROE -27.9%
FY 2021 5y median 11.5% FY 2025
ROIC -17.9%
FY 2021 5y median 9.0% FY 2025
ROA -16.0%
FY 2021 5y median 6.3% FY 2025
Growth (YoY)
Revenue -37.6%
FY 2021 FY 2025
Operating Income -515.2%
FY 2021 FY 2025
EPS (diluted) -683.3%
FY 2021 FY 2025
Free Cash Flow -94.7%
FY 2021 FY 2025
Financial Health
Current Ratio 1.1×
FY 2021 5y median 1.3× FY 2025
Quick Ratio 0.8×
FY 2021 5y median 1.0× FY 2025
Debt / Equity 0.3×
FY 2021 5y median 0.3× FY 2025
Net Debt / EBITDA -0.6×
FY 2021 5y median 0.6× FY 2025
Interest Coverage -20.1×
FY 2021 5y median 10.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 1.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 45.8% FY 2025
Annual · latest fiscal year ends 2025-12-31